The collaboration between Parexel and Partex is designed to leverage artificial intelligence-powered solutions to accelerate drug discovery and development. Parexel, a clinical research organization ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DURHAM, N.C. and FRANKFURT, Germany, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical ...

Parexel, a global CRO, will collaborate with digital pharma platform provider Partex to leverage AI in pursuit of drug discovery and development of biotech as well as to streamline clinical trials.

The private sector is a well-suited channel for the top biopharma to conduct more efficient clinical trials with easier and faster access to investigators and patients, a recent report revealed.

Collaboration to pair artificial intelligence proficiencies with clinical research expertise. Parexel, a contract research organization (CRO), and Partex, a data-to-drugs pharma platform, have inked a ...

FRANKFURT, Germany and MIAMI, March 17, 2025 (GLOBE NEWSWIRE) -- Partex NV and Fortress Biotech, Inc. (FBIO) (“Fortress”), an innovative biopharmaceutical company, today announced a strategic ...

Clinical research organisation Parexel and Partex have announced a collaboration to leverage artificial intelligence-driven solutions to accelerate drug discovery and development for biopharmaceutical ...

(RTTNews) - Partex NV and Fortress Biotech, Inc. (FBIO) have entered into a strategic collaboration aimed at accelerating the identification and evaluation of biopharmaceutical assets using Partex's ...

Partex Group, one of the largest family-owned manufacturing and service-based companies in Bangladesh, has split its business into two groups to improve management procedures. Sultana Hashem, wife of ...